ST6GAL1 and breast cancer: Regarding ST6GAL1 role in organ-site specific metastatic behavior, a recent study demonstrates that sEVs derived from breast cancer cells show increased α2,6 sialylation compared to their parental cells, and this increase is higher in the variant that metastasizes to the bone than in the one that metastasizes to the lung [46].